CVLB News and Press, Conversion Labs Inc From 12/11/20

NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, has officially launched its new Veritas MD telehealth platform, opening the door to greater market expansion with a growing port...

Conversion Labs (CVLB) to commence trading on Nasdaq on December 10, 2020, under the same ticker symbol “CVLB”."As the leading securities exchange for emerging growth stocks, we anticipate a Nasdaq listing will elevate our corporate profile and increase awareness of our growth s...

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received approval to uplist to the Nasdaq Capital Market ® . The company’s common stock will commence trading on the exchange ...

Conversion Labs, Inc. (CVLB) Q3 2020 Earnings Conference Call November 16, 2020 4:30 PM ET Company Participants Justin Schreiber – Chief Executive Officer Juan Piñeiro – Chief Financial Officer Stefan Galluppi – Chief Marketing Officer Conference Call Participants An...

Conversion Labs (CVLB): Q3 GAAP EPS of -$1.65.Revenue of $11.01M (+255.2% Y/Y)Press Release For further details see: Conversion Labs reports Q3 results

NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, reported results for the third quarter and first nine months ended September 30, 2020. All quarterly and first nine-month comp...

NEW YORK, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has appointed Roberto Simon to its board of directors and as the chair of its audit committee. Following his appointment, the board...

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, November 16, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended S...

NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc . (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has closed on approximately $14.5 million of a $15 million private placement with institutional investors at a purchase pr...

NEW YORK, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has signed a licensing agreement with Restorsea , a leading medical grade skincare technology platform. Conversion Labs plans...